Sickle Cell Disease Treatment: From Gene Therapies to New Drug Approvals

Please share to show your support

This is a research-based article on World Sickle Cell Disease Day, written by Venkataramana Konda. Read his other article at https://journals-times.com/2024/05/06/cutting-edge-thalassemia-treatments-and-research/ Gene Therapies Development over timeCasgevy and LyfgeniaCasgevyClinical TrialsResultsLyfgeniaClinical TrialsResultsAnalytical Assays for Cas9 and gRNANavigating Affordability ChallengesConclusionCheck our categories Sickle Cell Disease (SCD) is a prevalent, life-threatening monogenic blood disorder that is caused by a... Continue Reading →

Please share to show your support

Up ↑

Translate »